Get the Stockscreener App
1.12
0.88%
-0.010
After Hours:
1.12
Therapeuticsmd Inc stock is traded at $1.12, with a volume of 27,363.
It is down -0.88% in the last 24 hours and down -3.45% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.13
Open:
$1.13
24h Volume:
27,363
Relative Volume:
0.61
Market Cap:
$12.96M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.1132
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
-1.75%
1M Performance:
-3.45%
6M Performance:
+3.70%
1Y Performance:
-36.00%
1-Day Range:
$1.10
$1.146
1-Week Range:
$1.10
$1.23
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.12 | 13.08M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Custom watchlist performance reports with TherapeuticsMD Inc.Safe Entry Screening with Data Backed Analysis - Newser
What is the risk reward ratio of investing in TherapeuticsMD Inc. stockDaily Trading Strategy For Smart Trading - jammulinksnews.com
What are analysts’ price targets for TherapeuticsMD Inc. in the next 12 monthsRetirement Planning Target Finder Backed By Experts - jammulinksnews.com
What recovery options are there for TherapeuticsMD Inc.In-Depth Stock Trading Volume Analysis - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningFree Pattern Alert With ROI Driven Strategy - Newser
TherapeuticsMD Inc. stock trend forecastLow Capital High Return Stock Plans Reviewed - metal.it
Analyzing TherapeuticsMD Inc. with risk reward ratio chartsAlpha Trade Flow With Risk Calibration - Newser
Using data tools to time your TherapeuticsMD Inc. exitCapital Safe Picks with Consistent Gains - Newser
Will TherapeuticsMD Inc. see short term momentumWeekly Trend Screener with Momentum Picks - Newser
Quant Tools Rank TherapeuticsMD Inc. as High Risk High RewardEntry Alert Based on Volume Spikes Detected - metal.it
Candlestick Signal Suggests Reversal in TherapeuticsMD Inc.Triple Digit Growth Focused Trade Plan Reviewed - metal.it
Why TherapeuticsMD Inc. stock attracts strong analyst attentionPre-Market Stock Movement Summary and Review - Newser
What makes TherapeuticsMD Inc. stock price move sharplyMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Published on: 2025-07-30 00:06:51 - metal.it
Using flow based indicators on TherapeuticsMD Inc.Real-Time Analysis With Entry Targets In Progress - metal.it
TherapeuticsMD Inc. Stock Flags Risk Zone in Volatility IndexStep-by-Step Trade Signal Implementation Guide Ready - metal.it
Visual trend scoring systems applied to TherapeuticsMD Inc.Free Conservative Long Term Growth Plans - Newser
How TherapeuticsMD Inc. stock performs during market volatilityMomentum Screener with Buy and Sell Areas - Newser
What to expect from TherapeuticsMD Inc. in the next 30 daysFree ROI Boosting Trade Opportunity Calendar - Newser
TherapeuticsMD Inc. Crosses 200 Day MA — Signal or NoiseFast Exit and Entry Strategy Guide Offered - metal.it
TherapeuticsMD Inc. Flashes Buy Signal on Multi Timeframe ChartEntry Alert With Low Drawdown Strategy Noted - metal.it
When is TherapeuticsMD Inc. stock expected to show significant growthInvest confidently with actionable market data - jammulinksnews.com
How to interpret RSI for TherapeuticsMD Inc. stockReliable Setup Screener with Low Risk - Newser
Should I hold or sell TherapeuticsMD Inc. stock in 2025Expert guidance for superior capital growth - jammulinksnews.com
Published on: 2025-07-28 06:06:00 - jammulinksnews.com
What are the latest earnings results for TherapeuticsMD Inc.Access high-yield investment alerts now - jammulinksnews.com
Is TherapeuticsMD Inc. a growth stock or a value stockUnlock real-time stock alerts for quick profits - jammulinksnews.com
Is TherapeuticsMD Inc. a good long term investmentHigh-yield capital appreciation - PrintWeekIndia
What analysts say about TherapeuticsMD Inc. stockFree Stock Movement Tracking - Autocar Professional
What drives TherapeuticsMD Inc. stock priceRecord-breaking gains - PrintWeekIndia
Is TherapeuticsMD Inc. stock overhyped or has real potentialTremendous return on equity - jammulinksnews.com
TherapeuticsMD Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - Autocar Professional
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):